NO20061240L - Fremgangsmate for detektering av prokoagulant fosfolipid - Google Patents

Fremgangsmate for detektering av prokoagulant fosfolipid

Info

Publication number
NO20061240L
NO20061240L NO20061240A NO20061240A NO20061240L NO 20061240 L NO20061240 L NO 20061240L NO 20061240 A NO20061240 A NO 20061240A NO 20061240 A NO20061240 A NO 20061240A NO 20061240 L NO20061240 L NO 20061240L
Authority
NO
Norway
Prior art keywords
admixture
procoagulant phospholipid
procoagulant
plasma
phospholipid
Prior art date
Application number
NO20061240A
Other languages
English (en)
Inventor
Thomas Exner
Original Assignee
Haematex Res Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2003905172A external-priority patent/AU2003905172A0/en
Application filed by Haematex Res Pty Ltd filed Critical Haematex Res Pty Ltd
Publication of NO20061240L publication Critical patent/NO20061240L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • H—ELECTRICITY
    • H03—ELECTRONIC CIRCUITRY
    • H03L—AUTOMATIC CONTROL, STARTING, SYNCHRONISATION OR STABILISATION OF GENERATORS OF ELECTRONIC OSCILLATIONS OR PULSES
    • H03L7/00—Automatic control of frequency or phase; Synchronisation
    • H03L7/06—Automatic control of frequency or phase; Synchronisation using a reference signal applied to a frequency- or phase-locked loop
    • H03L7/16—Indirect frequency synthesis, i.e. generating a desired one of a number of predetermined frequencies using a frequency- or phase-locked loop
    • H03L7/22—Indirect frequency synthesis, i.e. generating a desired one of a number of predetermined frequencies using a frequency- or phase-locked loop using more than one loop

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Foreliggende åppfinnelse angår en fremgangsmåte for å bestemme mengden av prokoagulant fosfolipid i en prøve, hvor nevnte fremgangsmåte omfatter trin nene (i) til (iii) utført i følgende rekkefølge: (i) danne en blanding av prøven og et substratplasma som har blitt gjort fri eller hovedsakelig fri for prokoagulant fosfolipid tilstrekkelig til i det minste å redusere kapasiteten av substratplasma til å koagulere, hvori nevnte substratplasma har blitt gjort fri eller vesentlig fri for prokoagulant fosfolipid ved behandling med en fosfolipase; (ii) kontakte blandingen med et reagens for å aktivere koagulasjon av plasma ved betingelser hvor prokoagulant fosfolipid er den hastighetsbegrensende komponenten av blandingen; og (iii) bestemme koagulasjonstiden av blandingen.
NO20061240A 2003-09-22 2006-03-17 Fremgangsmate for detektering av prokoagulant fosfolipid NO20061240L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2003905172A AU2003905172A0 (en) 2003-09-22 Method for Detecting Procoagulant Phospholipid
PCT/AU2004/001291 WO2005029093A1 (en) 2003-09-22 2004-09-22 Method for detecting procoagulant phospholipid

Publications (1)

Publication Number Publication Date
NO20061240L true NO20061240L (no) 2006-05-31

Family

ID=34318306

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061240A NO20061240L (no) 2003-09-22 2006-03-17 Fremgangsmate for detektering av prokoagulant fosfolipid

Country Status (16)

Country Link
US (2) US20060228765A1 (no)
EP (1) EP1668373B1 (no)
JP (1) JP4559426B2 (no)
KR (1) KR20060113662A (no)
CN (1) CN1856710B (no)
AT (1) ATE447717T1 (no)
BR (1) BRPI0414293A (no)
CA (1) CA2539034A1 (no)
DE (1) DE602004023957D1 (no)
ES (1) ES2333872T3 (no)
IL (1) IL174156A0 (no)
MX (1) MXPA06003192A (no)
NO (1) NO20061240L (no)
RU (1) RU2006107577A (no)
WO (1) WO2005029093A1 (no)
ZA (1) ZA200601974B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005028018A1 (de) * 2005-06-16 2006-12-21 Dade Behring Marburg Gmbh Verfahren zur Standardisierung von Gerinnungstesten
IS2809B (is) * 2011-03-08 2012-10-15 Haskoli Islands Blóðstorkumæling
JP7153019B2 (ja) * 2016-12-14 2022-10-13 エフ．ホフマン－ラ ロシュ アーゲー 試料における干渉物質の決定
CN109490557A (zh) * 2018-11-23 2019-03-19 福州长庚医疗器械有限公司 一种运用血液凝固方式测量促凝剂效果的检测方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248553B1 (en) * 1998-10-22 2001-06-19 Atairgin Technologies, Inc. Enzyme method for detecting lysophospholipids and phospholipids and for detecting and correlating conditions associated with altered levels of lysophospholipids

Also Published As

Publication number Publication date
KR20060113662A (ko) 2006-11-02
BRPI0414293A (pt) 2006-11-07
US20090221012A1 (en) 2009-09-03
IL174156A0 (en) 2006-08-01
MXPA06003192A (es) 2006-12-14
RU2006107577A (ru) 2007-10-27
US20060228765A1 (en) 2006-10-12
ES2333872T3 (es) 2010-03-02
EP1668373B1 (en) 2009-11-04
CN1856710B (zh) 2012-06-13
CA2539034A1 (en) 2005-03-31
JP2007505636A (ja) 2007-03-15
CN1856710A (zh) 2006-11-01
JP4559426B2 (ja) 2010-10-06
WO2005029093A1 (en) 2005-03-31
EP1668373A4 (en) 2007-01-10
EP1668373A1 (en) 2006-06-14
ZA200601974B (en) 2007-05-30
ATE447717T1 (de) 2009-11-15
DE602004023957D1 (de) 2009-12-17

Similar Documents

Publication Publication Date Title
Antovic et al. Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting
RU2012104816A (ru) Стандартные лекарственные препараты и способы лечения тромбоза пероральным введением ингибитора фактора ха
DK0509086T3 (da) Fremgangsmåde til bestemmelse af koncentrationen af antikoagulanter
JP6499488B2 (ja) 凝固時間の測定方法、ループスアンチコアグラントの存否の判定方法及びループスアンチコアグラント検出用試薬キット
JP5903215B2 (ja) ループスアンチコアグラント検出用試薬キット及びループスアンチコアグラントの存否を判定する方法
JP4999613B2 (ja) 血液凝固測定用試薬及び血液凝固時間測定方法
ES2152531T3 (es) Prueba para determinar el riesgo de trombosis.
EP3743523A1 (en) Fibrinogen test
EP1367135A1 (en) Improved method for the assessment of thrombin formation in blood or plasma
IL174156A0 (en) Method for detecting procoagulant phospholipid
CA2156469C (en) Additive for diagnostic tests for determination of the coagulability of blood, method of reducing the influencing of diagnostic tests by heparin and the use of metal salts for these purposes
CA2883260C (en) Composition for use as an abnormal coagulation control plasma in in vitro assays
CA2389747C (en) Use of russell's viper venom-induced plasma factor xa activity to monitor the activity of factor xa inhibitors
Girolami et al. Chromogenic Substrate (S-2238) Prothrombin Assay in Prothrombin Deficiencies and Abnormalities. Lack of Identity with Clotting Assays in Congenital Dysprothrombinemias.
JP4262550B2 (ja) ループスアンチコアグラント検出試薬キット
WO2005111231A3 (en) Compositions, kit and one-step method for monitoring compounds having anti-factor xa and/or anti factor iia activities
WO2002022852A3 (en) Method for measuring antithrombin activity
AU729843B2 (en) Method for the functional detection of disorders in the protein C system
EP3983810A1 (en) Method for determining the risk of a thromboembolic event
Castro-López et al. Effects of four commercially available factor Xa proteins on the fluorogenic anti-factor Xa assay when monitoring unfractionated heparin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application